Honokiol increases ABCA1 expression level by activating retinoid X receptor beta.

Area of Science:

• Biochemistry
• Molecular Biology
• Pharmacology

Background:

• ATP-binding cassette transporter A1 (ABCA1) is crucial for high-density lipoprotein (HDL) metabolism and reverse cholesterol transport.
• ABCA1 expression is primarily regulated by nuclear receptors, including liver X receptor (LXR), retinoid X receptor (RXR), and peroxisome proliferator-activated receptors (PPARs).

Purpose of the Study:

• To identify natural compounds that can enhance ABCA1 expression.
• To elucidate the molecular mechanisms underlying honokiol's effect on ABCA1 regulation.

Main Methods:

• A reporter assay system using U251-MG cells stably expressing the human ABCA1 promoter-luciferase was employed for high-throughput screening.
• Cell-based assays were conducted to assess ABCA1 mRNA and protein levels, as well as the expression of related genes in U251-MG cells and THP-1 macrophages.
• Binding affinity assays were performed to investigate the interaction between honokiol and RXRbeta.

Main Results:

• Honokiol, extracted from Magnolia officinalis, was identified as a potent activator of the ABCA1 promoter.
• Honokiol dose-dependently increased ABCA1 mRNA and protein expression in U251-MG cells without inducing significant cytotoxicity.
• Honokiol also upregulated ABCA1, ABCG1, and apolipoprotein E (apoE) expression in THP-1 macrophages and demonstrated binding affinity to RXRbeta.

Conclusions:

• Honokiol is identified as a novel natural compound that upregulates ABCA1 expression.
• The mechanism involves honokiol acting as a ligand that binds to RXRbeta, thereby modulating ABCA1 expression.
• These findings suggest honokiol's potential therapeutic relevance in conditions related to cholesterol metabolism.